BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16912626)

  • 1. Sharing features of uncommon respiratory syncytial virus complications in infants.
    Piastra M; Caresta E; Tempera A; Langer A; Zorzi G; Pulitanò S; Chiaretti A; Genovese O; Viola L; Tortorolo L; Polidori G
    Pediatr Emerg Care; 2006 Aug; 22(8):574-8. PubMed ID: 16912626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection.
    Thorburn K
    Arch Dis Child; 2009 Feb; 94(2):99-103. PubMed ID: 18653625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pertussis is common in nonvaccinated infants hospitalized for respiratory syncytial virus infection.
    Korppi M; Hiltunen J
    Pediatr Infect Dis J; 2007 Apr; 26(4):316-8. PubMed ID: 17414394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The need for inotropic support in a subgroup of infants with severe life-threatening respiratory syncytial viral infection.
    Kim KK; Frankel LR
    J Investig Med; 1997 Oct; 45(8):469-73. PubMed ID: 9394100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute encephalopathy associated with respiratory syncytial virus infections in childhood. A literature review.
    Antonucci R; Fanos V
    Minerva Pediatr; 2005 Jun; 57(3):137-42. PubMed ID: 16170298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory syncytial virus infection in adults.
    Falsey AR
    Semin Respir Crit Care Med; 2007 Apr; 28(2):171-81. PubMed ID: 17458771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory syncytial virus infections in hospitalized infants: association between viral load, virus subgroup, and disease severity.
    Fodha I; Vabret A; Ghedira L; Seboui H; Chouchane S; Dewar J; Gueddiche N; Trabelsi A; Boujaafar N; Freymuth F
    J Med Virol; 2007 Dec; 79(12):1951-8. PubMed ID: 17935185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical, therapeutic and developmental aspects of acute bronchiolitis in Tunisia].
    Ben Jaballah N; Mnif K; Hedfi L; Hammami A; Khaldi F; Bennaceur B
    Cah Anesthesiol; 1996; 44(5):423-8. PubMed ID: 9183423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of concurrent bacterial infection in preterm infants hospitalized due to respiratory syncytial virus infection.
    Resch B; Gusenleitner W; Mueller WD
    Acta Paediatr; 2007 Apr; 96(4):495-8. PubMed ID: 17326757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is respiratory syncytial virus one of the causative agents for transient hyperphosphatasemia?].
    Goto M
    Rinsho Byori; 2002 Dec; 50(12):1146-9. PubMed ID: 12652683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk-Scoring Tool for respiratory syncytial virus prophylaxis in premature infants born at 33-35 completed weeks' gestational age in Canada.
    Paes B; Steele S; Janes M; Pinelli J
    Curr Med Res Opin; 2009 Jul; 25(7):1585-91. PubMed ID: 19469698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospitalized children with respiratory syncytial virus infection and neuromuscular impairment face an increased risk of a complicated course.
    Wilkesmann A; Ammann RA; Schildgen O; Eis-Hübinger AM; Müller A; Seidenberg J; Stephan V; Rieger C; Herting E; Wygold T; Hornschuh F; Groothuis JR; Simon A;
    Pediatr Infect Dis J; 2007 Jun; 26(6):485-91. PubMed ID: 17529864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pulmonary function in infants with respiratory syncytial virus bronchiolitis].
    Rao X; Liu X; Jiang Q; Jiao A; Jiang Y
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):182-5. PubMed ID: 11953156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of dual viral infection in infants admitted to a pediatric intensive care unit associated with severe bronchiolitis.
    Richard N; Komurian-Pradel F; Javouhey E; Perret M; Rajoharison A; Bagnaud A; Billaud G; Vernet G; Lina B; Floret D; Paranhos-Baccalà G
    Pediatr Infect Dis J; 2008 Mar; 27(3):213-7. PubMed ID: 18277932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks.
    Figueras-Aloy J; Carbonell-Estrany X; Quero-Jiménez J; Fernández-Colomer B; Guzmán-Cabañas J; Echaniz-Urcelay I; Doménech-Martínez E;
    Pediatr Infect Dis J; 2008 Sep; 27(9):788-93. PubMed ID: 18664927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of human metapneumovirus and respiratory syncytial virus co-infection in severe bronchiolitis.
    McNamara PS; Flanagan BF; Smyth RL; Hart CA
    Pediatr Pulmonol; 2007 Aug; 42(8):740-3. PubMed ID: 17588245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage impairment underlies airway occlusion in primary respiratory syncytial virus bronchiolitis.
    Reed JL; Brewah YA; Delaney T; Welliver T; Burwell T; Benjamin E; Kuta E; Kozhich A; McKinney L; Suzich J; Kiener PA; Avendano L; Velozo L; Humbles A; Welliver RC; Coyle AJ
    J Infect Dis; 2008 Dec; 198(12):1783-93. PubMed ID: 18980502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of respiratory failure due to respiratory syncytial virus pneumonia with natural surfactant.
    Vos GD; Rijtema MN; Blanco CE
    Pediatr Pulmonol; 1996 Dec; 22(6):412-5. PubMed ID: 9016476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Respiratory syncytial virus: as an etiological agent of respiratory tract infection in children and adults].
    Belino-Studzińska P; Pancer K
    Przegl Epidemiol; 2008; 62(4):767-75. PubMed ID: 19209739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal lavage leukotrienes in infants with RSV bronchiolitis.
    Da Dalt L; Callegaro S; Carraro S; Andreola B; Corradi M; Baraldi E
    Pediatr Allergy Immunol; 2007 Mar; 18(2):100-4. PubMed ID: 17338781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.